The anti-migraine drug sumatriptan reduced PACAP38-induced changes of STA and middle meningeal artery circumference and prevented headache in healthy volunteers when administered before PACAP38 infusion [13, 28]. The gene discussed is ADCYAP1; the disease is migraine disorder.